Healthcare provider profile · identity verified

Melanie E Zuo, M.D.

Geriatric Medicine · ANN ARBOR, MI · NPI 1598907529

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	492	145
Amlodipine Besylate	Amlodipine Besylate	439	126
Levothyroxine Sodium	Levothyroxine Sodium	389	108
Losartan Potassium	Losartan Potassium	256	85
Omeprazole	Omeprazole	241	73
Lisinopril	Lisinopril	209	58
Alendronate Sodium	Alendronate Sodium	181	51
Metoprolol Succinate	Metoprolol Succinate	181	55
Simvastatin	Simvastatin	166	40
Sertraline Hcl	Sertraline Hcl	164	45
Eliquis	Apixaban	163	44
Gabapentin	Gabapentin	145	49
Rosuvastatin Calcium	Rosuvastatin Calcium	144	46
Mirtazapine	Mirtazapine	134	45
Duloxetine Hcl	Duloxetine Hcl	133	43
Trazodone Hcl	Trazodone Hcl	130	44
Hydrochlorothiazide	Hydrochlorothiazide	122	33
Escitalopram Oxalate	Escitalopram Oxalate	111	32
Metformin Hcl	Metformin Hcl	108	33
Tamsulosin Hcl	Tamsulosin Hcl	102	31
Donepezil Hcl	Donepezil Hcl	98	32
Metoprolol Tartrate	Metoprolol Tartrate	98	28
Spironolactone	Spironolactone	98	30
Metformin Hcl Er	Metformin Hcl	86	25
Furosemide	Furosemide	79	29
Allopurinol	Allopurinol	68	19
Famotidine	Famotidine	68	24
Carvedilol	Carvedilol	67	19
Buspirone Hcl	Buspirone Hcl	62	17
Bupropion Xl	Bupropion Hcl	57	15
Pantoprazole Sodium	Pantoprazole Sodium	56	21
Xarelto	Rivaroxaban	55	13
Myrbetriq	Mirabegron	54	15
Venlafaxine Hcl Er	Venlafaxine Hcl	54	11
Finasteride	Finasteride	51	13
Tramadol Hcl	Tramadol Hcl	51	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	14
Valsartan	Valsartan	46	suppressed
Glipizide	Glipizide	45	11
Ezetimibe	Ezetimibe	44	suppressed
Ozempic	Semaglutide	42	suppressed
Baclofen	Baclofen	41	suppressed
Citalopram Hbr	Citalopram Hydrobromide	41	13
Jardiance	Empagliflozin	40	suppressed
Lorazepam	Lorazepam	38	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	35	27
Celecoxib	Celecoxib	34	suppressed
Fluticasone Propionate	Fluticasone Propionate	34	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	34	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	34	12
Pravastatin Sodium	Pravastatin Sodium	34	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	33	suppressed
Hydralazine Hcl	Hydralazine Hcl	32	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Pregabalin	Pregabalin	31	suppressed
Estradiol	Estradiol	30	15
Memantine Hcl	Memantine Hcl	30	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Glipizide Er	Glipizide	29	suppressed
Clopidogrel	Clopidogrel Bisulfate	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Propranolol Hcl Er	Propranolol Hcl	28	suppressed
Meloxicam	Meloxicam	27	suppressed
Methenamine Hippurate	Methenamine Hippurate	27	suppressed
Prednisone	Prednisone	27	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Montelukast Sodium	Montelukast Sodium	26	suppressed
Peg 3350-Electrolyte	Sodium Chloride/Nahco3/Kcl/Peg	26	26
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Oxycodone Hcl	Oxycodone Hcl	25	12
Memantine Hcl Er	Memantine Hcl	23	suppressed
Cephalexin	Cephalexin	22	19
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Potassium Chloride	Potassium Chloride	22	suppressed
Mirabegron Er	Mirabegron	21	suppressed
Nystatin	Nystatin	20	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Solifenacin Succinate	Solifenacin Succinate	20	suppressed
Alprazolam	Alprazolam	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	14
Warfarin Sodium	Warfarin Sodium	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	18	17
Triamcinolone Acetonide	Triamcinolone Acetonide	18	14
Amoxicillin	Amoxicillin	17	suppressed
Buprenorphine	Buprenorphine	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Hydrocortisone	Hydrocortisone	16	13
Ondansetron Odt	Ondansetron	16	suppressed
Risperidone	Risperidone	16	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Colchicine	Colchicine	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Galantamine Er	Galantamine Hbr	12	suppressed
Mometasone Furoate	Mometasone Furoate	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Diazepam	Diazepam	11	suppressed
Jantoven	Warfarin Sodium	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Methylphenidate Er	Methylphenidate Hcl	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Terazosin Hcl	Terazosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error